Abstract | BACKGROUND: METHODS AND RESULTS: Immunohistochemical analyses revealed the presence of VEGF and its receptors, VEGFR-1 (flt-1) and VEGFR-2 (KDR/flk-1), in the cytoplasm of tumor cells from 18 of 18 myxoma tissue specimens examined. Two different myxoma cell lines were established and constitutively secreted large amounts of VEGF as determined by enzyme-linked immunosorbent assay. The expression of VEGF, VEGFR-1, and VEGFR-2 mRNA was detected in both cell lines by reverse-transcriptase polymerase chain reaction. Myxoma cell proliferation, as determined by thymidine incorporation, was enhanced by the addition of VEGF in a dose-dependent manner, and cell proliferation was inhibited in a dose-dependent manner by the addition of a neutralizing VEGF antibody. CONCLUSIONS: These results indicate that cardiac myxoma cells possess a VEGF-autocrine system, which could contribute to the malignant potential of histologically benign myxomas through direct stimulation of tumor cell growth as well as through induction of angiogenesis.
|
Authors | Hironosuke Sakamoto, Tetsuo Sakamaki, Tsugiyasu Kanda, Yoko Tsuchiya, Mahito Sato, Hiroko Sato, Yuko Oyama, Yoshie Sawada, Jun-ichi Tamura, Ryozo Nagai, Masahiko Kurabayashi |
Journal | Circulation journal : official journal of the Japanese Circulation Society
(Circ J)
Vol. 68
Issue 5
Pg. 488-93
(May 2004)
ISSN: 1346-9843 [Print] Japan |
PMID | 15118294
(Publication Type: Journal Article)
|
Chemical References |
- Angiogenesis Inducing Agents
- Growth Substances
- RNA, Messenger
- VEGFA protein, human
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factor Receptor-1
- Vascular Endothelial Growth Factor Receptor-2
|
Topics |
- Angiogenesis Inducing Agents
(metabolism)
- Autocrine Communication
- Cell Division
(drug effects)
- Cells, Cultured
- Dose-Response Relationship, Drug
- Growth Substances
(metabolism)
- Heart Neoplasms
(metabolism, pathology)
- Humans
- Immunohistochemistry
(methods)
- Myxoma
(metabolism, pathology)
- RNA, Messenger
(metabolism)
- Staining and Labeling
- Vascular Endothelial Growth Factor A
(administration & dosage, genetics, metabolism, pharmacology)
- Vascular Endothelial Growth Factor Receptor-1
(genetics, metabolism)
- Vascular Endothelial Growth Factor Receptor-2
(genetics, metabolism)
|